Altamont Pharmaceutical Holdings LLC 13D/13G Filings for Soligenix, Inc. (SNGX)

Altamont Pharmaceutical Holdings LLC 13D and 13G filings for Soligenix, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2020-05-06
4:01 pm
Sale
2020-04-30 13G Soligenix, Inc.
SNGX
Altamont Pharmaceutical Holdings LLC 2,966
2.800%
-2,500decrease
(-45.74%)
Filing